Anti-insulin antibodies in diabetic dogs before and after treatment with different insulin preparations

Journal of Veterinary Internal Medicine

Volumn 22, Issue 6, 2008, Pages 1317-1325

  Davison, Lucy J ^a   Walding, B ^a   Herrtage, M E ^b   Catchpole, B ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Bovine insulin; Diabetes; Glycemic control; Porcine insulin

Indexed keywords

ANTIBODY; ANTIDIABETIC AGENT; INSULIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; CATTLE; DIABETES MELLITUS; DOG; DOG DISEASE; DRUG ADMINISTRATION; FEMALE; IMMUNOLOGY; MALE; SWINE;

ANIMALS; ANTIBODIES; CATTLE; DIABETES MELLITUS; DOG DISEASES; DOGS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HYPOGLYCEMIC AGENTS; INSULIN; MALE; SWINE;

ANIMALIA; BOVINAE; CANINE DISTEMPER VIRUS; CANIS FAMILIARIS; SUIDAE; SUS;

EID: 57149091966     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2008.0194.x     Document Type: Article

References (35)

1. Feldman EC, Nelson RW. Diabetes mellitus. In: Feldman EC, Nelson RW, eds. Canine and Feline Endocrinology and Reproduction. Philadelphia, PA: WB Saunders; 1996:339-391.
2. Watson PJ. Exocrine pancreatic insufficiency as an end stage of pancreatitis in four dogs. J Small Anim Pract 2003;44:306-312.
3. Catchpole B, Ristic JM, Fleeman LM, et al. Canine diabetes mellitus: Can old dogs teach us new tricks? Diabetologia 2005;48:1948-1956.
4. Hoenig M. Comparative aspects of diabetes mellitus in dogs and cats. Mol Cell Endocrinol 2002;197:221-229.
5. Thomas JW, Virta VJ, Nell LJ. Heterogeneity and specificity of human anti-insulin antibodies determined by isoelectric focusing. J Immunol 1985;134:1048-1052.
6. Davison LJ, Ristic JM, Herrtage ME, et al. Anti-insulin antibodies in dogs with naturally occurring diabetes mellitus. Vet Immunol Immunopathol 2003;91:53-60.
7. Fineberg SE, Galloway JA, Fineberg NS, et al. Effects of species of origin, purification levels, and formulation on insulin immunogenicity. Diabetes 1983;32:592-599.
8. Neubauer HP, Schone HH. The immunogenicity of different insulins in several animal species. Diabetes 1978;27:8-15.
9. Wilson RM, Douglas CA, Tattersall RB, et al. Immunogenicity of highly purified bovine insulin: A comparison with conventional bovine and highly purified human insulins. Diabetologia 1985;28:667-670.
10. Kurtz AB, Gray RS, Markanday S, et al. Circulating IgG antibody to protamine in patients treated with protamine-insulins. Diabetologia 1983;25:322-324.
11. Reeves WG, Kelly U. Insulin antibodies induced by bovine insulin therapy. Clin Exp Immunol 1982;50:163-170.
12. Kaplan C, Valdez JC, Chandrasekaran R, et al. Th1 and Th2 cytokines regulate proteoglycan-specific autoantibody isotypes and arthritis. Arthritis Res 2002;4:54-58.
13. Pilstrom B, Bjork L, Bohme J. Demonstration of a TH1 cytokine profile in the late phase of NOD insulitis. Cytokine 1995;7:806-814.
14. Koczwara K, Schenker M, Schmid S, et al. Characterization of antibody responses to endogenous and exogenous antigen in the nonobese diabetic mouse. Clin Immunol 2003;106:155-162.
15. Hoppu S, Ronkainen MS, Kimpimaki T, et al. Insulin autoantibody isotypes during the prediabetic process in young children with increased genetic risk of type 1 diabetes. Pediatr Res 2004;55:236-242.
16. Tian J, Chau C, Kaufman DL. Insulin selectively primes Th2 responses and induces regulatory tolerance to insulin in pre-diabetic mice. Diabetologia 1998;41:237-240.
17. Rendell M, Hamilton RG, Drew HM, et al. Exacerbation of diabetes mellitus by antibodies to exogenous insulin. Am J Med Sci 1981;282:18-26.
18. Mazza G, Whiting AH, Day MJ, et al. Preparation of monoclonal antibodies specific for the subclasses of canine IgG. Res Vet Sci 1994;57:140-145.
19. Hoenig M, Dawe DL. A qualitative assay for beta cell antibodies. Preliminary results in dogs with diabetes mellitus. Vet Immunol Immunopathol 1992;32:195-203.
20. Hampe CS, Ortqvist E, Rolandsson O, et al. Species-specific autoantibodies in type 1 diabetes. J Clin Endocrinol Metab 1999;84:643-648.
21. Schlosser M, Koczwara K, Kenk H, et al. In insulin-autoantibody-positive children from the general population, antibody affinity identifies those at high and low risk. Diabetologia 2005;48:1830-1832.
22. Ziegler AG, Vardi P, Ricker AT, et al. Radioassay determination of insulin autoantibodies in NOD mice. Correlation with increased risk of progression to overt diabetes. Diabetes 1989;38:358-363.
23. Reeves WG, Kelly U. Insulin antibodies induced by bovine insulin therapy. Clin Exp Immunol 1982;50:163-170.
24. Nachreiner RF, Refsal KR, Graham PA, et al. Prevalence of serum thyroid hormone autoantibodies in dogs with clinical signs of hypothyroidism. J Am Vet Med Assoc 2002;220:466-471.
25. Nachreiner RF, Refsal KR, Graham PA, et al. Prevalence of autoantibodies to thyroglobulin in dogs with nonthyroidal illness. Am J Vet Res 1998;59:951-955.
26. Dixon RM, Mooney CT. Canine serum thyroglobulin autoantibodies in health, hypothyroidism and non-thyroidal illness. Res Vet Sci 1999;66:243-246.
27. Barker JM. Type 1 diabetes-associated autoimmunity: Natural history, genetic associations and screening. J Clin Endocrinol Metab 2006;91:1210-1217.
28. Nell LJ, Thomas JW. Frequency and specificity of protamine antibodies in diabetic and control subjects. Diabetes 1988;37:172-176.
29. Kurtz AB, Gray RS, Markanday S, et al. Circulating IgG antibody to protamine in patients treated with protamine-insulins. Diabetologia 1983;25:322-324.
30. Nell LJ, Hulbert C, Thomas JW. Human insulin autoantibody fine specificity and H and L chain use. J Immunol 1989;142:3063-3069.
31. Day MJ, Mazza G. Tissue immunoglobulin G subclasses observed in immune-mediated dermatopathy, deeppyoderma and hypersensitivity dermatitis in dogs. Res Vet Sci 1995;58:82-89.
32. Rodríguez-Cortés A, Fernández-Bellón H, Ramis A, et al. Leishmania-specific isotype levels and their relationship with specific cell-mediated immunity parameters in canine leishmaniasis. Vet Immunol Immunopathol 2007;116:190-198.
33. Nakano T, Nagata A. ELISAs for free light chains of human immunoglobulins using monoclonal antibodies: Comparison of their specificity with available polyclonal antibodies. J Immunol Methods 2003;275:9-17.
34. Bistritzer T, Sack J, Theodor R, et al. Correlation between HbA1c, purified insulins, diabetic control, and insulin antibodies in diabetic children. Horm Res 1984;20:178-185.
35. Bolli GB, Dimitriadis GD, Pehling GB, et al. Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. N Engl J Med 1984;310:1706-1711.